Hot flashes are the #1 menopause complaint, yet millions of women can’t — or prefer not to — use hormone therapy.
That’s why the newest data on Cendifensine is getting so much attention.
Black women are navigating menopause with less support, more symptoms, and higher rates of medical dismissal — and now we finally have the data to prove it. The Black Women’s Health Imperative has released the largest U.S. survey ever conducted on Black women’s menopause experiences, uncovering major gaps in care, information, and equity. Here’s what the findings reveal — and why this research matters for every woman in midlife.
In a historic move, the FDA has requested the removal of the black box warning from hormone therapy used for menopause. Experts say this long-overdue update reflects modern science—and could help women reclaim access to safe, effective symptom relief.
The FDA has approved Lynkuet (Elinzanetant), a groundbreaking non-hormonal medication that targets the brain pathways behind hot flashes. For women who can’t or prefer not to use hormone therapy, this represents a major step forward in menopause care.
A year-long study of Elinzanetant (Lynkuet) reveals lasting relief from hot flashes and improved sleep without hormones. Here’s what you need to know about this breakthrough non-hormonal option.
UK approves first testosterone cream for postmenopausal women—sparking hope for future FDA approval in the U.S.
Elinzanetant (Lynkuet) is a new non-hormonal therapy under FDA review that could finally provide relief from hot flashes for women who can’t or prefer not to take hormone therapy. Promising trial results offer hope for midlife symptom relief.
For over 20 years, low-dose vaginal estrogen has carried a frightening FDA black box warning—despite no evidence of the risks it lists. Experts now say this outdated label is keeping women from a safe, effective treatment for painful and life-altering menopause symptoms.
Fezolinetant (Veozah) is the first non-hormonal drug approved to tackle menopausal hot flashes—but a rare liver injury warning means careful monitoring is essential. Could this new option finally provide relief for women who can’t or don’t want hormone therapy?
A major 2024 review of the Women’s Health Initiative has rewritten the story on hormone therapy. For women under 60 or within 10 years of menopause, the benefits may outweigh the risks—marking a turning point in how doctors and patients approach treatment.
Could a weekly pill shift the menopause timeline? Researchers are exploring how one drug might change the future of women’s health.
A major study reveals women’s heart health declines rapidly after menopause, making this a crucial time for screening, prevention, and awareness.
Could menopause one day be optional? Scientists are exploring radical new ways to delay or even prevent it, from ovarian tissue freezing to groundbreaking hormonal research.